4.5 Article

Illness burden and medical comorbidity in the Systematic Treatment Enhancement Program for Bipolar Disorder

Journal

ACTA PSYCHIATRICA SCANDINAVICA
Volume 125, Issue 4, Pages 303-308

Publisher

WILEY
DOI: 10.1111/j.1600-0447.2011.01794.x

Keywords

bipolar disorder; medical burden; staging; age at onset; comorbidity; outcome; treatment; mania; depression; course; diabetes; smoking; cardiovascular

Categories

Funding

  1. National Institute for Translational Medicine, Brazil
  2. National Institute of Mental Health
  3. Astra-Zeneca
  4. Eli Lilly
  5. Janssen-Cilag
  6. Servier
  7. CNPq
  8. CAPES
  9. NARSAD
  10. Stanley Medical Research Institute
  11. Stanley Medical Research Foundation
  12. MBF
  13. NHMRC
  14. Beyond Blue
  15. Geelong Medical Research Foundation
  16. Bristol Myers Squibb
  17. Glaxo SmithKline
  18. Glaxo SmithKline, Organon
  19. Novartis
  20. Mayne Pharma
  21. Pamlab
  22. Shire

Ask authors/readers for more resources

Objective: Coexisting chronic medical conditions are common in bipolar disorder. Here, we report the prevalence and correlates of medical comorbidity in patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). We were particularly interested in associations between variables reflecting illness chronicity and burden with comorbid medical conditions. Method: We used intake data from the open-label component of the STEP-BD. History of medical comorbidity was obtained from the affective disorders evaluation, and its presence was the outcome of interest. The sample size in analyses varied from 3399 to 3534. We used multiple Poisson regression to obtain prevalence ratios. Results: The prevalence of any medical comorbidity in the sample was 58.8%. In addition to demographic variable, several clinical characteristics were associated with the frequency of medical comorbidity. Having more than 10 previous mood episodes, childhood onset, smoking, lifetime comorbidity with anxiety, and substance use disorders were independently associated with having a medical comorbidity in the final multivariate model. Conclusion: The results presented here reveal strong associations between variables related to illness chronicity and medical burden in bipolar disorder. This lends further support to recent multidimensional models incorporating medical morbidity as a core feature of bipolar disorder.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available